0001209191-20-004811.txt : 20200124 0001209191-20-004811.hdr.sgml : 20200124 20200124161226 ACCESSION NUMBER: 0001209191-20-004811 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200122 FILED AS OF DATE: 20200124 DATE AS OF CHANGE: 20200124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CALSADA CRISPINA CENTRAL INDEX KEY: 0001606833 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35670 FILM NUMBER: 20545626 MAIL ADDRESS: STREET 1: C/O AMBRX, INC. STREET 2: 10975 N. TORREY PINES RD. CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Regulus Therapeutics Inc. CENTRAL INDEX KEY: 0001505512 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264738379 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10628 SCIENCE CENTER DRIVE STREET 2: SUITE 225 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-202-6300 MAIL ADDRESS: STREET 1: 10628 SCIENCE CENTER DRIVE STREET 2: SUITE 225 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-01-22 0 0001505512 Regulus Therapeutics Inc. RGLS 0001606833 CALSADA CRISPINA C/O REGULUS THERAPEUTICS 10628 SCIENCE CENTER DR. #225 SAN DIEGO CA 92121 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 1.31 2020-01-22 4 A 0 150000 0.00 A 2030-01-21 Common Stock 150000 150000 D The stock option will vest ratably on a monthly basis over a 48 month period subject to the reporting person's continuous service to Regulus through each such vesting date. Christopher Aker, Attorney in Fact 2020-01-24